Endocrinology: diabetes technology, dynamic testing, and visit complexity
Endocrinology revenue is concentrated in cognitive work and diabetes technology, and both are documentation-sensitive. Visit level rests on medical decision making across multiple chronic conditions with prescription management and lab interpretation, or on total time, and the note has to make that reasoning visible rather than listing results. Continuous glucose monitoring adds placement, training, and interpretation services, each with distinct coverage criteria and minimum data requirements that plans check closely before paying.
Dynamic testing and in-office procedures are the other half. Stimulation and suppression studies involve timed draws and prolonged supervision that must be documented to support what is billed, and thyroid ultrasound with fine needle aspiration involves separate imaging guidance and lesion-specific rules. Diabetes self-management training carries its own coverage limits, initial and follow-up hour allowances, and referral requirements. We verify device coverage criteria before dispensing and align visit documentation with the decision making actually performed.
Coding and documentation focus
- ✓Continuous glucose monitoring services — Placement, patient training, and data interpretation are distinct services with their own coverage criteria and minimum recording requirements.
- ✓Visit level by decision making — Multiple chronic conditions with medication management and independent lab interpretation support higher levels when the reasoning is documented.
- ✓Dynamic stimulation and suppression testing — Timed draws and the supervision provided need to be recorded to support prolonged service and testing components.
- ✓Thyroid ultrasound with aspiration — Imaging guidance and aspiration are reported per lesion under specific rules rather than per encounter.
Denials we prevent on these claims
- ✓Glucose monitoring interpretation without the minimum required data days — verified before billing.
- ✓Device coverage criteria not met at dispensing — screened against the policy in advance.
- ✓Visit level unsupported because the note lists results without reasoning — flagged pre-bill.
- ✓Aspiration and guidance units miscounted across lesions — corrected at coding.
Frequently asked questions
What is required to bill continuous glucose monitoring interpretation?
A minimum number of days of recorded data within the period, a documented interpretation and management plan based on that data, and satisfaction of the plan coverage criteria for the device itself. Interpretation billed on insufficient data is the most common denial in this area.
How do we support a higher-level endocrinology visit?
By documenting the decision making rather than the data: which conditions were addressed, what medications were adjusted and why, which labs you interpreted independently, and what risk the plan carries. Time-based selection is an alternative when total time on the date is recorded.